{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:12:42Z","timestamp":1773717162714,"version":"3.50.1"},"reference-count":79,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RADDF"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Nanophytosomes represent an effective choice for topical drug delivery\nsystems thanks to their small size, general non-toxicity, ease of functionalization and high surface\nto volume ratio. The goal of the current study was to investigate the potential benefits of using Hypericum\nperforatum extract nanogel as a means of improving skin penetration and prolonging skin\ndeposition in dermatitis similar to psoriasis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Nanophytosomes (NPs) were developed, optimised and thoroughly characterised. The optimised\nNPs were then placed in a Carbopol gel base matrix and tested ex-vivo (skin penetration and\ndermatokinetic) and in-vivo (antipsoriatic activity in an Imiquimod-induced psoriatic rat model).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The optimised NPs had a spherical form and entrapment efficiency of 69.68% with a nanosized\nand zeta potential of 168nm and -10.37mV, respectively. XRD spectra and transmission\nelectron microscopy tests confirmed the plant botanical encapsulation in the NPs. Following 60\ndays of storage at 40 \u00b1 2\u00b0C\/75 \u00b1 5% RH, the optimised formula remained relatively stable. As\ncompared to extract gel, nano-gel showed a much-improved ex vivo permeability profile and considerable\ndrug deposition in the viable epidermal-dermal layers. When developed nano-gel was applied\ntopically to a rat model of psoriasis, it demonstrated distinct in vivo anti-psoriatic efficacy in\nterms of drug activity and reduction of epidermal thickness in comparison to other formulations and\nthe control. ELISA and histopathologic studies also demonstrated that nano-organogel had improved\nskin integrity and downregulated inflammatory markers (IL-17, IL-6, IFN-\u03b3 and MCP-1).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Findings suggest that a developed plant botanicals-based nanogel has a potential for\nthe treatment of psoriasis-like dermatitis with better skin retention and effectiveness.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0126673878288239240415041832","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T06:14:21Z","timestamp":1716185661000},"page":"138-154","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dermal Delivery of <i>Hypericum perforatum<\/i> (L.) Loaded Nanogel: Formulation\nto Preclinical Psoriasis Assessment"],"prefix":"10.2174","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3029-9053","authenticated-orcid":true,"given":"Neelam","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Pharmacy, I.T.S. College of Pharmacy, Delhi-Meerut Road, Ghaziabad -201206, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubh Deep","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, I.T.S. College of Pharmacy, Delhi-Meerut Road, Ghaziabad -201206, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6198-2907","authenticated-orcid":true,"given":"Puneet","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of\nPharmacy, Amity Institute of Pharmacy, Amity University, Uttar Pradesh, Sector 125, Noida-201313, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faraat","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Regulatory, Botswana Medicines Regulatory Authority, Plot 112, Gaborone International Finance\nPark Gaborone, Botswana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of\nPharmacy, Amity Institute of Pharmacy, Amity University, Uttar Pradesh, Sector 125, Noida-201313, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-82335-1_1","author":"Vestita M.","year":"2022","unstructured":"Vestita M.; Tedeschi P.; Bonamonte D.; Anatomy and physiology of the skin. Textb Plast Reconstr Surg Basic Princ New Perspect  [Internet]2022,3-13","journal-title":"Textb Plast Reconstr Surg Basic Princ New Perspect"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"Rendon A.","year":"2019","unstructured":"Rendon A.; Sch\u00e4kel K.; Psoriasis pathogenesis and treatment. Int J Mol Sci  2019,20(6),1475","journal-title":"Int J Mol Sci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/PTT.S327310","volume":"12","author":"Ortiz-Lopez L.I.","year":"2022","unstructured":"Ortiz-Lopez L.I.; Choudhary V.; Bollag W.B.; Updated perspectives on keratinocytes and psoriasis: Keratinocytes are more than innocent bystanders. Psoriasis  2022,12,73-87","journal-title":"Psoriasis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"Korman N.J.","year":"2020","unstructured":"Korman N.J.; Management of psoriasis as a systemic disease: What is the evidence? Br J Dermatol  2020,182(4),840-848","journal-title":"Br J Dermatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","volume":"50","author":"Deng Y.","year":"2016","unstructured":"Deng Y.; Chang C.; Lu Q.; The inflammatory response in psoriasis: A comprehensive review. Clin Rev Allergy Immunol  2016,50(3),377-389","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.3390\/ijms22094983","volume":"22","author":"Petit R.G.","year":"2021","unstructured":"Petit R.G.; Cano A.; Ortiz A.; Psoriasis: From pathogenesis to pharmacological and nano-technological-based therapeutics. Int J Mol Sci  2021,22(9),4983","journal-title":"Int J Mol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1177\/1535370217710637","volume":"242","author":"Desmet E.","year":"2017","unstructured":"Desmet E.; Ramadhas A.; Lambert J.; Van Gele M.; In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research. Exp Biol Med  2017,242(11),1158-1169","journal-title":"Exp Biol Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2340\/00015555-3384","volume":"100","author":"Dand N.","year":"2020","unstructured":"Dand N.; Mahil S.; Capon F.; Smith C.; Simpson M.; Barker J.; Psoriasis and genetics. Acta Derm Venereol  2020,100(3),55-65","journal-title":"Acta Derm Venereol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/jdv.16926","volume":"35","author":"Nast A.","year":"2021","unstructured":"Nast A.; Smith C.; Spuls P.I.; EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris Part 2: Specific clinical and comorbid situations. J Eur Acad Dermatol Venereol  2021,35(2),281-317","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.4103\/ijmr.IJMR_1296_17","volume":"146","author":"Thappa D.","year":"2017","unstructured":"Thappa D.; Munisamy M.; Research on psoriasis in India: Where do we stand? Indian J Med Res  2017,146(2),147-149","journal-title":"Indian J Med Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e142067","DOI":"10.1172\/jci.insight.142067","volume":"5","author":"Jiang Y.","year":"2020","unstructured":"Jiang Y.; Tsoi L.C.; Billi A.C.; Cytokinocytes: The diverse contribution of keratinocytes to immune responses in skin. JCI Insight  2020,5(20),e142067","journal-title":"JCI Insight"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.acc.2020.04.004","volume":"100","author":"de Alcantara C.C.","year":"2021","unstructured":"de Alcantara C.C.; Reiche E.M.V.; Sim\u00e3o A.N.C.; Cytokines in psoriasis. Adv Clin Chem  2021,100,171-204","journal-title":"Adv Clin Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40495-021-00277-2","volume":"8","author":"Sharma R.K.","year":"2022","unstructured":"Sharma R.K.; Sharma M.R.; Mahendra A.; Kumar S.; Role of inflammatory cytokines in pathophysiology of psoriasis. Curr Pharmacol Rep  2022,8(2),99-105","journal-title":"Curr Pharmacol Rep"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1080\/1744666X.2022.2011720","volume":"17","author":"Seyedmirzaei H.","year":"2021","unstructured":"Seyedmirzaei H.; Rezaei N.; Cytokine alterations in psoriasis: An updated review. Expert Rev Clin Immunol  2021,17(12),1323-1335","journal-title":"Expert Rev Clin Immunol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.biopha.2018.07.156","volume":"107","author":"Pradhan M.","year":"2018","unstructured":"Pradhan M.; Alexander A.; Singh M.R.; Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother  2018,107,447-463","journal-title":"Biomed Pharmacother"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jconrel.2013.05.020","volume":"170","author":"Pradhan M.","year":"2013","unstructured":"Pradhan M.; Singh D.; Singh M.R.; Novel colloidal carriers for psoriasis: Current issues, mechanistic insight and novel delivery approaches. J Control Release  2013,170(3),380-395","journal-title":"J Control Release"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1056\/NEJMoa021359","volume":"349","author":"Heydendael V.M.R.","year":"2003","unstructured":"Heydendael V.M.R.; Spuls P.I.; Opmeer B.C.; Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med  2003,349(7),658-665","journal-title":"N Engl J Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.amjcard.2011.06.054","volume":"108","author":"Micha R.","year":"2011","unstructured":"Micha R.; Imamura F.; Wyler von Ballmoos M.; Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol  2011,108(9),1362-1370","journal-title":"Am J Cardiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.2147\/IJN.S156412","volume":"13","author":"Abu Hashim I.","year":"2018","unstructured":"Abu Hashim I.; Abo El-Magd N.; El-Sheakh A.; Hamed M.; Abd El-Gawad A.E.G.; Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: Ex vivo\u2013in vivo evaluation study. Int J Nanomedicine  2018,13,1059-1079","journal-title":"Int J Nanomedicine"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/phpp.12088","volume":"30","author":"Richard E.G.","year":"2014","unstructured":"Richard E.G.; H\u00f6nigsmann H.; Phototherapy, psoriasis, and the age of biologics. Photodermatol Photoimmunol Photomed  2014,30(1),3-7","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/molecules27030591","volume":"27","author":"Nowak-Perlak M.","year":"2022","unstructured":"Nowak-Perlak M.; Szpadel K.; Jab\u0142o\u0144ska I; Pizon M; Wo\u017aniak M.; Promising strategies in plant-derived treatments of psoriasis-update of in vitro, in vivo, and clinical trials studies. Molecules  2022,27(3),591","journal-title":"Molecules"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"Armstrong A.W.","year":"2020","unstructured":"Armstrong A.W.; Read C.; Pathophysiology, clinical presentation, and treatment of psoriasis. JAMA  2020,323(19),1945-1960","journal-title":"JAMA"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s12247-022-09698-y","volume":"18","author":"Dawoud M.H.S.","year":"2023","unstructured":"Dawoud M.H.S.; Abdel-Daim A.; Nour M.S.; Sweed N.M.; A quality by design paradigm for albumin-based nanoparticles: formulation optimization and enhancement of the antitumor activity. J Pharm Innov  2023,18(3),1395-1414","journal-title":"J Pharm Innov"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"29080","DOI":"10.1039\/D1RA06087B","volume":"11","author":"Mohd Nordin U.U.","year":"2021","unstructured":"Mohd Nordin U.U.; Ahmad N.; Salim N.; Mohd Yusof N.S.; Lipid-based nanoparticles for psoriasis treatment: A review on conventional treatments, recent works, and future prospects. RSC Advances  2021,11(46),29080-29101","journal-title":"RSC Advances"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/1871530320666200604162258","volume":"21","author":"Ramanunny A.K.","year":"2021","unstructured":"Ramanunny A.K.; Wadhwa S.; Thakur D.; Singh S.K.; Kumar R.; Treatment modalities of psoriasis: A focus on requisite for topical nanocarrier. Endocr Metab Immune Disord Drug Targets  2021,21(3),418-433","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"102663","DOI":"10.1016\/j.jddst.2021.102663","volume":"64","author":"Khan A.","year":"2021","unstructured":"Khan A.; Qadir A.; Ali F.; Aqil M.; Phytoconstituents based nanomedicines for the management of psoriasis. J Drug Deliv Sci Technol  2021,64,102663","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4103\/jpgm.JPGM_155_17","volume":"63","author":"Thappa D.M.","year":"2017","unstructured":"Thappa D.M.; Malathi M.; Topical therapy of psoriasis. J Postgrad Med  2017,63(4),210-212","journal-title":"J Postgrad Med"},{"key":"ref=28","doi-asserted-by":"publisher","DOI":"10.1201\/b10787-12","author":"Klemow K.M.","year":"2011","unstructured":"Klemow K.M.; Bartlow A.; Crawford J.; Kocher N.; Shah J.; Ritsick M.; Medical Attributes of St. John\u2019s Wort (Hypericum perforatum). Herb Med Biomol Clin Asp   http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK92750\/2011","journal-title":"Herb Med Biomol Clin Asp"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/biom11030371","volume":"11","author":"Gendrisch F.","year":"2021","unstructured":"Gendrisch F.; Haarhaus B.; Krieger N.; Quirin K.W.; Schempp C.M.; W\u00f6lfle U.; The effect of herbal medicinal products on psoriasis-like keratinocytes. Biomolecules  2021,11(3),371","journal-title":"Biomolecules"},{"key":"ref=30","first-page":"1045","volume":"25","author":"Nobakht S.Z.","year":"2022","unstructured":"Nobakht S.Z.; Akaberi M.; Mohammadpour A.H.; Tafazoli Moghadam A.; Emami S.A.; Hypericum perforatum: Traditional uses, clinical trials, and drug interactions. Iran J Basic Med Sci  2022,25(9),1045-1058","journal-title":"Iran J Basic Med Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.3390\/ijms21218108","volume":"21","author":"Novelli M.","year":"2020","unstructured":"Novelli M.; Masiello P.; Beffy P.; Menegazzi M.; Protective role of st. john\u2019s wort and its components hyperforin and hypericin against diabetes through inhibition of inflammatory signaling: evidence from in vitro and in vivo studies. Int J Mol Sci  2020,21(21),8108","journal-title":"Int J Mol Sci"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0034-1394504","volume":"80","author":"W\u00f6lfle U.","year":"2014","unstructured":"W\u00f6lfle U.; Seelinger G.; Schempp C.M.; Topical application of St. John\u2019s wort (Hypericum perforatum). Planta Med  2014,80(2-3),109-120","journal-title":"Planta Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/gels9050353","volume":"9","author":"Mouro C.","year":"2023","unstructured":"Mouro C.; Gomes A.P.; Gouveia I.C.; Emulsion electrospinning of PLLA\/PVA\/Chitosan with Hypericum perforatum L. as an antibacterial nanofibrous wound dressing. Gels  2023,9(5),353","journal-title":"Gels"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s11164-016-2623-7","volume":"43","author":"Pourhojat F.","year":"2017","unstructured":"Pourhojat F.; Sohrabi M.; Shariati S.; Mahdavi H.; Asadpour L.; Evaluation of poly \u03b5-caprolactone electrospun nanofibers loaded with Hypericum perforatum extract as a wound dressing. Res Chem Intermed  2017,43(1),297-320","journal-title":"Res Chem Intermed"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/21691401.2016.1167699","volume":"45","author":"Moghddam S.M.M.","year":"2017","unstructured":"Moghddam S.M.M.; Ahad A.; Aqil M.; Imam S.S.; Sultana Y.; Optimization of nanostructured lipid carriers for topical delivery of nimesulide using Box\u2013Behnken design approach. Artif Cells Nanomed Biotechnol  2017,45(3),617-624","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"101775","DOI":"10.1016\/j.jddst.2020.101775","volume":"57","author":"Qadir A.","year":"2020","unstructured":"Qadir A.; Aqil M.; Ali A.; Nanostructured lipidic carriers for dual drug delivery in the management of psoriasis: Systematic optimization, dermatokinetic and preclinical evaluation. J Drug Deliv Sci Technol  2020,57,101775","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","volume":"188","author":"Hald Albertsen C.","year":"2022","unstructured":"Hald Albertsen C.; Kulkarni J.A.; Witzigmann D.; Lind M.; Petersson K.; Simonsen J.B.; The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv Drug Deliv Rev  2022,188,114416","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/08982104.2020.1867166","volume":"32","author":"Salem H.F.","year":"2022","unstructured":"Salem H.F.; Nafady M.M.; Ewees M.G.E.L.D.; Hassan H.; Khallaf R.A.; Rosuvastatin calcium-based novel nanocubic vesicles capped with silver nanoparticles-loaded hydrogel for wound healing management: Optimization employing Box\u2013Behnken design: in vitro and in vivo assessment. J Liposome Res  2022,32(1),45-61","journal-title":"J Liposome Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e01088","DOI":"10.1016\/j.heliyon.2018.e01088","volume":"4","author":"Danaei M.","year":"2018","unstructured":"Danaei M.; Kalantari M.; Raji M.; Probing nanoliposomes using single particle analytical techniques: Effect of excipients, solvents, phase transition and zeta potential. Heliyon  2018,4(12),e01088","journal-title":"Heliyon"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.3390\/nano12172954","volume":"12","author":"Tamilarasan N.","year":"2022","unstructured":"Tamilarasan N.; Yasmin B.M.; Anitha P.; Box\u2013behnken design: Optimization of proanthocyanidin-loaded transferosomes as an effective therapeutic approach for osteoarthritis. Nanomaterials  2022,12(17),2954","journal-title":"Nanomaterials"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s43094-021-00299-z","volume":"7","author":"Akram W.","year":"2021","unstructured":"Akram W.; Garud N.; Design expert as a statistical tool for optimization of 5-ASA-loaded biopolymer-based nanoparticles using Box Behnken factorial design. Fut J Pharma Sci  2021,7(1),146","journal-title":"Fut J Pharma Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/polym14010144","volume":"14","author":"Sharaf N.S.","year":"2021","unstructured":"Sharaf N.S.; Shetta A.; Elhalawani J.E.; Mamdouh W.; Applying box\u2013behnken design for formulation and optimization of plga-coffee nanoparticles and detecting enhanced antioxidant and anticancer activities. Polymers  2021,14(1),144","journal-title":"Polymers"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"40102","DOI":"10.1021\/acsami.2c05812","volume":"14","author":"Dong R.","year":"2022","unstructured":"Dong R.; Zhao Y.; Song Y.; Fu N.; Omee S.S.; Dey S.; DeepXRD, a deep learning model for predicting XRD spectrum from material composition. ACS Appl Mater Interfaces  2022,14,40102-40115","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/10837450.2023.2231069","volume":"28","author":"Luo X.","year":"2023","unstructured":"Luo X.; Saleem A.; Shafique U.; Rivaroxaban-loaded SLNs with treatment potential of deep vein thrombosis: In-vitro, in-vivo, and toxicity evaluation. Pharm Dev Technol  2023,28(7),625-637","journal-title":"Pharm Dev Technol"},{"key":"ref=45","first-page":"591","volume":"75","author":"Padhye S.G.","year":"2013","unstructured":"Padhye S.G.; Nagarsenker M.S.; Simvastatin solid lipid nanoparticles for oral delivery: Formulation development and in vivo evaluation. Indian J Pharm Sci  2013,75(5),591-598","journal-title":"Indian J Pharm Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1080\/02652048.2019.1612475","volume":"36","author":"Kumar S.","year":"2019","unstructured":"Kumar S.; Singh K.K.; Rao R.; Enhanced anti-psoriatic efficacy and regulation of oxidative stress of a novel topical babchi oil (Psoralea corylifolia) cyclodextrin-based nanogel in a mouse tail model. J Microencapsul  2019,36(2),140-155","journal-title":"J Microencapsul"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ijbiomac.2019.09.013","volume":"141","author":"Rezk A.I.","year":"2019","unstructured":"Rezk A.I.; Obiweluozor F.O.; Choukrani G.; Park C.H.; Kim C.S.; Drug release and kinetic models of anticancer drug (BTZ) from a pH-responsive alginate polydopamine hydrogel: Towards cancer chemotherapy. Int J Biol Macromol  2019,141,388-400","journal-title":"Int J Biol Macromol"},{"key":"ref=48","first-page":"32","volume":"28","author":"Chimkode R.","year":"2009","unstructured":"Chimkode R.; Patil M.B.; Jalalpure S.; Pasha T.Y.; Sarkar S.; A study of hepatoprotective activity of hedyotis corymbosa. linn, in albino rats. Anc Sci Life  2009,28(4),32-35","journal-title":"Anc Sci Life"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"292","DOI":"10.4274\/tjps.galenos.2018.44265","volume":"16","author":"Das K.","year":"2019","unstructured":"Das K.; Deb S.; Karanth T.; Phytochemical screening and metallic ion content and its impact on the antipsoriasis activity of aqueous leaf extracts of calendula officinalis and phlebodium decumanum in an animal experiment model. Turkish J Pharma Sci  2019,16(3),292-302","journal-title":"Turkish J Pharma Sci"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13205-021-02841-5","volume":"11","author":"Alhakamy NA","year":"2021","unstructured":"Alhakamy NA; Aldawsari HM; Ali J; Gupta DK; Warsi MH; Bilgrami AL; Brucine-loaded transliposomes nanogel for topical delivery in skin cancer: Statistical optimization, in vitro and dermatokinetic evaluation. 3 Biotech  2021,11,1-288","journal-title":"3 Biotech"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tiv.2014.09.007","volume":"29","author":"Guth K.","year":"2015","unstructured":"Guth K.; Sch\u00e4fer-Korting M.; Fabian E.; Landsiedel R.; van Ravenzwaay B.; Suitability of skin integrity tests for dermal absorption studies in vitro. Toxicol In Vitro  2015,29(1),113-123","journal-title":"Toxicol In Vitro"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.sjbs.2020.02.014","volume":"27","author":"Ahmad N.","year":"2020","unstructured":"Ahmad N.; Ahmad R.; Mohammed Buheazaha T.; Salman AlHomoud H.; Al-Nasif H.A.; Sarafroz M.; A comparative ex vivo permeation evaluation of a novel 5-Fluorocuracil nanoemulsion-gel by topically applied in the different excised rat, goat, and cow skin. Saudi J Biol Sci  2020,27(4),1024-1040","journal-title":"Saudi J Biol Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2174\/1389200218666170306104042","volume":"18","author":"Thotakura N.","year":"2017","unstructured":"Thotakura N.; Kumar P.; Wadhwa S.; Raza K.; Katare P.; Dermatokinetics as an important tool to assess the bioavailability of drugs by topical nanocarriers. Curr Drug Metab  2017,18(5),404-411","journal-title":"Curr Drug Metab"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1208\/s12249-016-0681-1","volume":"18","author":"Kumar P.","year":"2017","unstructured":"Kumar P.; Kumar R.; Singh B.; Biocompatible phospholipid-based mixed micelles for tamoxifen delivery: Promising evidences from in vitro anticancer activity and dermatokinetic studies. AAPS PharmSciTech  2017,18(6),2037-2044","journal-title":"AAPS PharmSciTech"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jaci.2020.04.034","volume":"147","author":"Sch\u00f6n M.P.","year":"2021","unstructured":"Sch\u00f6n M.P.; Manzke V.; Erpenbeck L.; Animal models of psoriasis\u2014highlights and drawbacks. J Allergy Clin Immunol  2021,147(2),439-455","journal-title":"J Allergy Clin Immunol"},{"key":"ref=56","first-page":"79","volume":"5","author":"Pourhoseingholi M.A.","year":"2012","unstructured":"Pourhoseingholi M.A.; Baghestani A.R.; Vahedi M.; How to control confounding effects by statistical analysis. Gastroenterol Hepatol Bed Bench  2012,5(2),79-83","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1177\/026119299802600313","volume":"26","author":"Howard B.","year":"1998","unstructured":"Howard B.; Book review: Guide for the care and use of laboratory animals. Altern Lab Anim  1998,26(3),363-364","journal-title":"Altern Lab Anim"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.biopha.2018.12.075","volume":"111","author":"Dev S.K.","year":"2019","unstructured":"Dev S.K.; Choudhury P.K.; Srivastava R.; Sharma M.; Antimicrobial, anti-inflammatory and wound healing activity of polyherbal formulation. Biomed Pharmacother  2019,111,555-567","journal-title":"Biomed Pharmacother"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/1389200218666170222145908","volume":"18","author":"Milan A.S.","year":"2017","unstructured":"Milan A.S.; Calpena Campmany A.C.; Naveros B.C.; Antioxidant nanoplatforms for dermal delivery: Melatonin. Curr Drug Metab  2017,18(5),437-453","journal-title":"Curr Drug Metab"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s43188-019-00013-5","volume":"36","author":"Reduan F.H.","year":"2020","unstructured":"Reduan F.H.; Shaari R.M.; Sayuti N.S.A.; Acute and subacute dermal toxicity of ethanolic extract of Melastoma malabathricum leaves in Sprague-Dawley rats. Toxicol Res  2020,36(3),203-210","journal-title":"Toxicol Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/ijp.IJP_506_19","volume":"53","author":"Prasad S.K.","year":"2021","unstructured":"Prasad S.K.; Parmar K.M.; Jagtap C.S.; Katare N.T.; Dhobi M.; Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent. Indian J Pharmacol  2021,53(2),125-131","journal-title":"Indian J Pharmacol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/molecules24112157","volume":"24","author":"Yang B.Y.","year":"2019","unstructured":"Yang B.Y.; Cheng Y.G.; Liu Y.; Datura metel l. ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production through TLR7\/8\u2013MyD88\u2013NF-\u03baB\u2013NLRP3 inflammasome pathway. Molecules  2019,24(11),2157","journal-title":"Molecules"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.intimp.2017.04.022","volume":"48","author":"Chen H.","year":"2017","unstructured":"Chen H.; Lu C.; Liu H.; Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-\u03baB pathway. Int Immunopharmacol  2017,48,110-117","journal-title":"Int Immunopharmacol"},{"key":"ref=64","first-page":"3993","author":"Ezzell J.L.","year":"2000","unstructured":"Ezzell J.L.; Pressurized fluid extraction: Non-environmental applications. Encycl Sep Sci  2000,3993-3999","journal-title":"Encycl Sep Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s13562-019-00490-7","volume":"28","author":"Mir M.Y.","year":"2019","unstructured":"Mir M.Y.; Hamid S.; Kamili A.N.; Hassan Q.P.; Sneak peek of Hypericum perforatum L.: Phytochemistry, phytochemical efficacy and biotechnological interventions. J Plant Biochem Biotechnol  2019,28(4),357-373","journal-title":"J Plant Biochem Biotechnol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"120990","DOI":"10.1016\/j.ijpharm.2021.120990","volume":"607","author":"Maji R.","year":"2021","unstructured":"Maji R.; Omolo C.A.; Jaglal Y.; A transferosome-loaded bigel for enhanced transdermal delivery and antibacterial activity of vancomycin hydrochloride. Int J Pharm  2021,607,120990","journal-title":"Int J Pharm"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2019.09.016","volume":"315","author":"Yu M.","year":"2019","unstructured":"Yu M.; Yuan W.; Li D.; Schwendeman A.; Schwendeman S.P.; Predicting drug release kinetics from nanocarriers inside dialysis bags. J Control Release  2019,315,23-30","journal-title":"J Control Release"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"Zhou X.","year":"2022","unstructured":"Zhou X.; Chen Y.; Cui L.; Shi Y.; Guo C.; Advances in the pathogenesis of psoriasis: From keratinocyte perspective. Cell Death Dis  2022,13(1),81","journal-title":"Cell Death Dis"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/17435390903276941","volume":"3","author":"Berg J.M.","year":"2009","unstructured":"Berg J.M.; Romoser A.; Banerjee N.; Zebda R.; Sayes C.M.; The relationship between pH and zeta potential of ~ 30 nm metal oxide nanoparticle suspensions relevant to in vitro toxicological evaluations. Nanotoxicology  2009,3(4),276-283","journal-title":"Nanotoxicology"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12247-021-09549-2","volume":"17","author":"Zaichik S.","year":"2022","unstructured":"Zaichik S.; Steinbring C.; Friedl J.D.; Bernkop-Schn\u00fcrch A.; Development and in vitro characterization of transferrin-decorated nanoemulsion utilizing hydrophobic ion pairing for targeted cellular uptake. J Pharm Innov  2022,17(3),690-700","journal-title":"J Pharm Innov"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejpb.2021.06.006","volume":"166","author":"Sk\u00f3ra B.","year":"2021","unstructured":"Sk\u00f3ra B.; Piechowiak T.; Szychowski K.A.; Gmi\u0144ski J.; Entrapment of silver nanoparticles in L-\u03b1-phosphatidylcholine\/cholesterol-based liposomes mitigates the oxidative stress in human keratinocyte (HaCaT) cells. Eur J Pharm Biopharm  2021,166,163-174","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"968","DOI":"10.3390\/biom10070968","volume":"10","author":"Algahtani M.S.","year":"2020","unstructured":"Algahtani M.S.; Ahmad M.Z.; Nourein I.H.; Ahmad J.; Co-Delivery of imiquimod and curcumin by nanoemugel for improved topical delivery and reduced psoriasis-like skin lesions. Biomolecules  2020,10(7),968","journal-title":"Biomolecules"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"20057","DOI":"10.1021\/acsnano.2c07843","volume":"16","author":"Lee W.H.","year":"2022","unstructured":"Lee W.H.; Rho J.G.; Yang Y.; Hyaluronic acid nanoparticles as a topical agent for treating psoriasis. ACS Nano  2022,16(12),20057-20074","journal-title":"ACS Nano"},{"key":"ref=74","author":"Badri T.","year":"2022","unstructured":"Badri T.; Kumar P.; Oakley A.M.;  Plaque Psoriasis StatPearls   http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430879\/2022","journal-title":"Plaque Psoriasis StatPearls"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"111945","DOI":"10.1016\/j.colsurfb.2021.111945","volume":"206","author":"Rapalli V.K.","year":"2021","unstructured":"Rapalli V.K.; Sharma S.; Roy A.; Singhvi G.; Design and dermatokinetic evaluation of Apremilast loaded nanostructured lipid carriers embedded gel for topical delivery: A potential approach for improved permeation and prolong skin deposition. Colloids Surf B Biointerfaces  2021,206,111945","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"e151911","DOI":"10.1172\/jci.insight.151911","volume":"6","author":"Shao S.","year":"2021","unstructured":"Shao S.; Chen J.; Swindell W.R.; Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris. JCI Insight  2021,6(20),e151911","journal-title":"JCI Insight"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.clindermatol.2007.09.021","volume":"25","author":"Tschachler E.","year":"2007","unstructured":"Tschachler E.; Psoriasis: The epidermal component. Clin Dermatol  2007,25(6),589-595","journal-title":"Clin Dermatol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"13330","DOI":"10.3390\/ijms232113330","volume":"23","author":"Purzycka-Bohdan D.","year":"2022","unstructured":"Purzycka-Bohdan D.; Nedoszytko B.; Zab\u0142otna M; Gle\u0144 J; Szczerkowska-Dobosz A; Nowicki RJ.; Chemokine profile in psoriasis patients in correlation with disease severity and pruritus. Int J Mol Sci  2022,23(21),13330","journal-title":"Int J Mol Sci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/ijms18122514","volume":"18","author":"Boche\u0144ska K","year":"2017","unstructured":"Boche\u0144ska K; Smoli\u0144ska E; Moskot M; Jak\u00f3bkiewicz-Banecka J; Gabig-Cimi\u0144ska M.; Models in the research process of psoriasis. Int J Mol Sci  2017,18(12),2514","journal-title":"Int J Mol Sci"}],"container-title":["Recent Advances in Drug Delivery and Formulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0126673878288239240415041832","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/230069\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0126673878288239240415041832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:14:34Z","timestamp":1724991274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/230069\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0126673878288239240415041832","relation":{},"ISSN":["2667-3878"],"issn-type":[{"value":"2667-3878","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}